The GCC Market-Entry Checklist

The Gulf is one of the most attractive medical device opportunities in the world — and one of the easiest to get wrong. Before your product ever lands in the region, these six decisions shape whether you build a profitable position or burn budget. Use this as a planning checklist.

1. Which market first?

The GCC is six countries, not one. Saudi Arabia offers scale; the UAE offers speed and prestige; smaller markets offer efficient add-ons. Trying to enter everywhere at once usually means succeeding nowhere. Sequence deliberately.

2. What is your regulatory classification?

Your device class determines your timeline, your documentation burden and your cost. Confirm it early — it is the foundation everything else is built on.

3. Authorised Representative — who holds your licence?

You need a local entity to register. Decide whether that role sits with your distributor or with an independent representative, and understand the long-term implications of each.

4. Distributor — partner or bottleneck?

The right distributor accelerates you; the wrong one traps you in an exclusive agreement with no performance. Vet on coverage, capability, existing portfolio conflicts, and public-sector standing.

5. Public sector, private sector, or both?

Selling to government hospitals means NUPCO qualification and tender strategy. Selling to private networks means commercial relationships and positioning. The two channels need different plans.

6. Pricing and budget reality

Build a realistic budget that includes registration, representation, logistics and the time-to-first-revenue gap. Underestimating the runway is the most common reason promising entries stall.

Get these six right and the Gulf becomes a durable growth market. Get them wrong and even a great product struggles.

This article is general guidance, not regulatory, legal or financial advice. Every product and market is different.